Forgot Password?
Return to Course Listing

CME: The United States CTEPH Proceedings 2021, Part 2

ACCREDITATION EXPIRED: December 14, 2022

Activity Description / Statement of Need:

***Please note that, in order to access these course materials, you must create a user profile if you do not already have one. Your profile one ScientiaCME's website is unrelated to your profile on North American Thrombosis Forum's (NATF's) website.***

 

The content of this online activity was originally presented as part of a live event. It is divided into three videos. Learners must view all videos in their entirety and complete a post-activity assessment and evaluation before they are eligible for continuing credit.

The North American Thrombosis Forum's (NATF’s) "United States CTEPH Proceedings 2021" provides a multidisciplinary framework for the evaluation and management of patients with chronic thromboembolic pulmonary hypertension (CTEPH). The activity is comprised of didactic presentations, debates, and panel discussions involving national and international experts in the field.

Covered topics in the series will include:

  • The epidemiology of chronic thromboembolic disease in the US
  • Contemporary approaches to diagnosing CTEPH
  • The latest in surgical advancements
  • The role of pulmonary hypertension (PH) targeted medical therapy and balloon pulmonary angioplasty (BPA) in the management of inoperable CTEPH

Target Audience:

This activity has been designed to provide internists, pulmonologists, cardiologists, cardiovascular surgeons, interventional cardiologists and radiologists, anesthesiologists, thoracic radiologists, nurses, and allied healthcare professionals with state-of-the-art information to evaluate and manage patients with CTEPH.

Supported by educational grants from: Abbott Laboratories; Acceleron Pharma Inc.; Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson; and Boston Scientific Corporation.

This internet enduring material activity is part of a series of activities. Participation in this activity is free of charge.

Release Date: December 15, 2021 -- Expiration Date: December 14, 2022

Faculty: Multiple Faculty,

Agenda

Learning Objectives

By the end of the session the participant will be able to:

  • Describe the latest diagnostic and evaluative approaches to patients with suspected chronic thromboembolic disease
  • Discuss advances in pulmonary thromboendarterectomy for patients with chronic thromboembolic disease and CTEPH and apply that information to a patient case
  • Define the role of medical therapy in selected patient groups with CTEPH

Accreditation

ACCME Activity #201861289

ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.


Faculty Disclosure and Resolution of COI

  • Marc de Perrot, MD, MSc, FRCSC: Speaker honoraria – Bayer; Paid Consultant – Actelion, Roche; Advisor – AstraZeneca
  • Kim M. Kerr, MD: Research Support – Bayer; Consultant – Actelion
  • Michael M. Madani, MD: Consultant – Bayer/Merck, Janssen/Actelion, Wexler Surgical
  • Michael Zhen-Yu Tong, MD, MBA: Speaker honoraria – Abbott, Abiomed
  • Cameron Wright, MD: Paid Consultant – Bayer

 

The following individuals have no conflicts of interest to disclose:

  • Jonathan Haft, MD
  • Victor Pretorius, MBchB
  • Charles Turck, PharmD, BCPS, BCCCP, President, ScientiaCME (Reviewer)

Instructions

  • Read the learning objectives above
  • Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
  • View the online activity. You may view this is in more than one session, and may pause or repeat any portion of the presentation if you need to.
  • Minimum participation threshold: Take the post-test. A score of 70% or higher is required to pass and proceed to the activity evaluation.
  • Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately.

Cultural/Linguistic Competence & Health Disparities

System Requirements

PC
Windows 7 or above
Internet Explorer 8
*Adobe Acrobat Reader
MAC
Mac OS 10.2.8
Safari or Chrome or Firefox
*Adobe Acrobat Reader
Internet Explorer is not supported on the Macintosh

*Required to view Printable PDF Version

Perform Pre-Test (optional)

Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.